Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · IEX Real-Time Price · USD
60.83
+0.21 (0.35%)
At close: Apr 19, 2024, 4:00 PM
60.84
+0.01 (0.02%)
After-hours: Apr 19, 2024, 6:17 PM EDT
Vaxcyte Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Vaxcyte stock have an average target of 89.5, with a low estimate of 70 and a high estimate of 113. The average target predicts an increase of 47.13% from the current stock price of 60.83.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vaxcyte stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +56.17% | Apr 10, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $69 → $113 | Strong Buy | Maintains | $69 → $113 | +85.76% | Mar 12, 2024 |
| Needham | Needham | Strong Buy Maintains $73 → $95 | Strong Buy | Maintains | $73 → $95 | +56.17% | Feb 28, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $67 → $80 | Strong Buy | Maintains | $67 → $80 | +31.51% | Jan 2, 2024 |
| Mizuho | Mizuho | Strong Buy Initiates $69 | Strong Buy | Initiates | $69 | +13.43% | Dec 7, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.40
from -4.14
EPS Next Year
-4.57
from -4.40
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 129.6M | 631.9M |
| Avg | n/a | n/a | n/a | 77.5M | 295.0M |
| Low | n/a | n/a | n/a | 52.8M | 147.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 715.1% |
| Avg | - | - | - | - | 280.6% |
| Low | - | - | - | - | 89.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.93 | -3.17 | -2.67 | -2.60 | -2.31 |
| Avg | -4.40 | -4.57 | -4.65 | -3.98 | -3.23 |
| Low | -4.66 | -5.48 | -5.56 | -5.28 | -5.03 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.